Michael Andrew Chambers Insider Profile

18 Followers
Michael Andrew Chambers, Director at Sarepta Therapeutics, holds 292.31K shares in Sarepta Therapeutics (Ticker: SRPT). Most recently, Michael Andrew Chambers Bought $37,038 shares of Sarepta Therapeutics on Aug 20, 2024 for an estimated value of 4.96M.
tipranks
Michael Andrew Chambers

Michael Andrew Chambers
Sarepta Therapeutics (SRPT)
Director

Ranked #23,199 out of 99,218 Corporate Insiders

Profitable Transactions

83%
5 out of 6 Profitable Transactions

Average Return

+8.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$36M
100.00%
A breakdown of Michael Andrew Chambers's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
Director
Roles that Michael Andrew Chambers holds in companies

Most Profitable Insider Trade

Stock:
Sarepta Therapeutics
(SRPT)
Rating:Informative Buy
Date:Aug 14, 2023 - Aug 14, 2024
Return:+18.30%
The most profitable trade made by Michael Andrew Chambers

Michael Andrew Chambers's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sarepta Therapeutics
Aug 20, 2024
Director
Informative Buy
4.96M
$35.55M
Success Rate for
SRPT
5 out of 6 profitable transactions on
SRPT
83%
Average Return for
SRPT
Average return per transaction on
SRPT
+8.55%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 06, 2022
Uninformative Buy
$0.00
-
$0.00
Aug 22, 2022
Informative Buy
$5.00M
-
$108.27
+5.50%
Mar 08, 2023
Uninformative Buy
$0.00
-
$0.00
Aug 11, 2023
Informative Buy
$3.70M
-
$106.14
+16.00%
Aug 14, 2023
Informative Buy
$2.56M
-
$108.05
+18.30%
List of latest transactions for each holding click on a transaction to see Michael Andrew Chambers's performance on stock

Michael Andrew Chambers insider profile FAQ

What is the percentage of profitable transactions made by Michael Andrew Chambers?
The percentage of profitable transactions made by Michael Andrew Chambers is 83%.
    What is the average return per transaction made by Michael Andrew Chambers?
    The average return per transaction made by Michael Andrew Chambers is 8.50%.
      What stocks does Michael Andrew Chambers hold?
      Michael Andrew Chambers holds: SRPT stocks.
        What was Michael Andrew Chambers’s latest transaction?
        Michael Andrew Chambers latest transaction was an Informative Buy of $4.96M.
          What was Michael Andrew Chambers's most profitable transaction?
          Michael Andrew Chambers’s most profitable transaction was an Informative Buy of SRPT stock on August 14, 2023. The return on the trade was 18.30%.
            What is Michael Andrew Chambers's role in Sarepta Therapeutics?
            Michael Andrew Chambers's role in Sarepta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.